Affiliation:
1. Department of Surgery University of Southern California Keck School of Medicine Los Angeles California USA
2. Division of Thoracic Surgery, Department of Surgery University of Southern California Keck School of Medicine Los Angeles California USA
Abstract
AbstractEsophageal cancer remains a significant cause of cancer‐related mortality among men and women in the United States. The utility of surgery, as either an immediate or delayed resection in the form of esophagectomy following neoadjuvant therapy in local‐regionally advanced esophageal cancer, remains controversial. While neoadjuvant therapy followed by immediate surgery is a guideline‐concordant treatment, emerging data suggests that active surveillance with delayed resection at the time of local‐regional recurrence may be considered.
Subject
Oncology,General Medicine,Surgery
Reference30 articles.
1. Surveillance Epidemiology and End Results (SEER) Program Esophageal Cancer. Populations—total U.S. (1969‐2020); U.S. 1969‐2020 Counties National Cancer Institute DCCPS Surveillance Research Program released January 2022;2022.
2. National Comprehensive Cancer Network. Version 5.2022. Esophageal and esophagogastric junction cancers; 2022. Accessed December 6 2022.https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf
3. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
4. Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma
5. Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline